As of 2025-07-09, the ROE (Return on Equity) of Aeolus Pharmaceuticals Inc (AOLS) is -111.4%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
Date | Value |
---|---|
2016-09-30 | -111.4% |
2015-09-30 | 311% |
2014-09-30 | -5% |
2013-09-30 | -455% |
2012-09-30 | -8.4% |
2011-09-30 | -1.3% |
2010-09-30 | 96.7% |
2009-09-30 | 198.3% |
2008-09-30 | 285.6% |
2007-09-30 | -255.9% |